Last update: May 1, 2016

Josamycin Propionate

Low Risk for breastfeeding


Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

A macrolide antibiotic that is approved for pediatric use. Frequently used in young infants

At latest update no published data on excretion into breast milk were found.

It has higher molecular weight and shorter half-life elimination span than other macrolide antibiotics like azithromycin and claritormycin that are excreted into breast milk in negligible amount.
Until more published information about this drug regarding breastfeeding appears, it may be preferable a known and safer alternative, especially during the neonatal period and in cases of prematurity.

Early exposure to macrolide antibiotics (especially erythromycin) has been linked to hypertrophic pyloric stenosis, even through breast milk, being it a reason to avoid them during the first month of breastfeeding.

Take into account the possible negative results of bacterial cultures among febrile infants when their mothers are on antibiotics, as well as the possibility of gastroenteritis by altering the intestinal flora.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Josamycin Propionate is also known as Josamycin.


Josamycin Propionate in other languages or writings:

Group

Josamycin Propionate belongs to this group or family:

Tradenames

Main tradenames from several countries containing Josamycin Propionate in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 35 %
Molecular weight 828 daltons
Protein Binding 15 %
Tmax 1 hours
T1/2 1,5 hours

References

  1. Periti P, Mazzei T, Mini E, Novelli A. Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I). Clin Pharmacokinet. 1989 Abstract
  2. Wildfeuer A, Lemme JD. [The pharmacokinetics of josamycin]. Arzneimittelforschung. 1985 Abstract

Total visits

1,122

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM